Skip to content
value.today

Vitagene, Inc.

Total raised
$12 M
2 rounds on record
Latest round
$6 M
Jul 2023
First round on record
Feb 2016
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Vitagene, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jul 2023$6 MNo. 2$2 to $10 million

Vitagene, Inc.: Raise no. 2, Jul 2023

Investors in this round

20 investors had bought by the notice of Jul 25, 2023: 20 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $8 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Mehdi Maghsoodnia · Executive Officer, Director
  • Mostafa Ronaghi · Director
  • Neil Hunt · Director
  • Reza Malek · Director
  • Shantanu Agrawal · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mehdi Maghsoodnia, President. Source: SEC Form D, newest notice filed Jul 25, 2023. Read the notice at the SEC.

equitySEC
Feb 2016$5 MNo. 1$2 to $10 million

Vitagene, Inc.: Raise no. 1, Feb 2016

Investors in this round

18 investors had bought by the notice of Feb 24, 2016: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Mehdi Maghsoodnia · Executive Officer, Director
  • Reza Malek · Executive Officer, Director
  • Lyon Wong · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mehdi Maghsoodnia, Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 24, 2016. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Vitagene, Inc. chose not to state its revenue in its newest notice of a funding round (Jul 2023).

    SEC Form D · Jul 2023

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jul 2023

That is all the official record says: Vitagene, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Vitagene, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 20 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Vitagene, Inc.
NameRoleNamed in
Mehdi MaghsoodniaExecutive officerJul 2023
Reza MalekExecutive officerFeb 2016
Mehdi MaghsoodniaDirectorJul 2023
Mostafa RonaghiDirectorJul 2023
Neil HuntDirectorJul 2023
Reza MalekDirectorJul 2023
Shantanu AgrawalDirectorJul 2023
Lyon WongDirectorFeb 2016